Clinical observation on treating non-alcoholic steatohepatitis with the Shengjiang decoction

冯高飞,陈若
DOI: https://doi.org/10.3969/j.issn.1674-7860.2015.14.006
2015-01-01
Abstract:Objective:To evaluate clinical effects of the Shengjiang decoction on non-alcoholic steatohepatitis. Methods:80 cases of non-alcoholic steatohepatitis were randomly divided into the Shengjiang decoction group and the polyene phosphatidylcholine capsule group, each group for 40 cases. 12 weeks for a course. After the treatment, syndromes, liver function, blood lipids and type-B ultrasonic results in two groups were observed, and clinical effects in two groups were evaluated. Results:In the Shengjiang decoction group, the total efficiency was 85%, better than that in the polyene phosphatidylcholine capsule group (67.50%). The difference was statistically significant (P<0.01). After the treatment, liver function and blood lipids in each group were significantly different. The difference was statistically significant (P<0.01). Differences between two groups were statistically significant (P<0.01). In the Shengjiang decoction group, improvement of type-B ultrasonic was 87.50%, better than that in the polyene phosphatidylcholine capsule group (75.00%). The difference was statistically significant (P<0.05). Conclusion:The Shengjiang decoction was effective on non-alcoholic steatohepatitis, better than the polyene phosphatidylcholine capsule.
What problem does this paper attempt to address?